Background: Acute kidney injury (AKI) is a feared complication in intensive care unit (ICU) patients where the kidneys rapidly fail to regulate fluid and/or metabolic waste products in the body. AKI is quite common in ICU patients, with variable incidence rates depending on the population studied and definitions used. The structural damage and/or functional impairment of the kidneys are caused by chronic risk factors acting together with acute illnesses and/or injuries. Treatment of AKI is correction of the underlying condition and general supportive care of organ functions; the most severe cases need renal replacement therapy (RRT) temporarily replacing the normal blood-filtering function of the kidneys. AKI is associated with increased short-time morbidity, mortality and health care costs.
Survivors are also predisposed to chronic kidney disease and have reduced long-time survival. Methods: The aim of this thesis was to investigate the occurrence of AKI in trauma and outof-hospital cardiac arrest (OHCA) patients, and to explore the association between AKI and patient outcome. Another aim was to evaluate the quality of RRT in trauma patients, and to examine the utility of urine AKI biomarkers in OHCA patients. Results: The main findings in the trauma patients were that AKI with need of RRT occurred seldom and was associated with modest mortality. Renal recovery was excellent as none of the survivors were dependent on chronic RRT one year after trauma. Male sex was identified as a risk factor for AKI, and increasing patient age as a risk factor for mortality. The quality of RRT in trauma patients could be improved enhancing the technical skills of personnel, and ensuring that patients receive sufficient RRT dose. In the OHCA patients, AKI occurred in about half of the patients successfully resuscitated, and presence of AKI was associated with unfavorable 6-month mortality and neurological recovery. AKI patients with and without RRT had comparable mortality and neurological outcome, even after excluding patients where RRT was withheld due to futility. The concentrations of urine cystatin C and NGAL (neutrophil gelatinase-associated lipocalin) at admission and day 3 were independent risk factors for AKI, mortality and poor neurological outcome in resuscitated comatose OHCA patients, whereas [TIMP (Tissue inhibitor of metalloproteinase)-2]9[IGFBP (Insulin-like growth factor binding protein binding protein)7] levels only predicted AKI at admission. The discriminating power was not uniformly improved in models combining biomarkers and clinical parameters compared to the use of biomarkers alone. Conclusions: AKI was a complication during post-resuscitation care of trauma and OHCA patients associated with unfavorable outcome. In trauma patients, several quality aspects of RRT could be improved. In cardiac arrest patients, increased biomarker levels in spot urine early after cardiac arrest were risk factors for subsequent AKI and poor outcome, but did not have a discriminating power high enough to be recommended for use in clinical practice.
